MENU
INNPF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Innocan Pharma (INNPF) Ownership - Who owns Innocan Pharma?
Profile
Industry
N/A
Address
13215 Bee Cave Parkway
Phone
+1 512 538-2300
Employees
78
Web
https://www.shpreit.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
86.96M
P/E Ratio
N/A
Total Cash
37.84M
Projected Growth
N/A
Total Debt
1.46B
Revenue
736.13M
Risk (Beta)
N/A
Dividend Yield
0.07
Total Cash/Share
0.15
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
INNPF
Capitalization
87M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
0.07
Total Cash
37.8M
Total Cash/Share
0.15
Total Debt
1.46B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
736M
ROE
N/A
Book Value
911M
P/B Ratio
10.41
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.08M
Current Ratio
0.53
Current Revenue Per Employee
2274807.80
Dividends Per Share - Security
N/A
EBITDA
212M
Float
N/A
Float - Current
N/A
Gross Income Margin
37.62
Revenue To Assets
-0.94
Shares Held By Institutions
29.7M
Shares Outstanding - Current
249M
Total Liabilities
1.54B
Total Volume MTD
N/A
Value
1
Gain YTD
7359.953
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
13215 Bee Cave Parkway
Phone
+1 512 538-2300
Employees
78
Web
https://www.shpreit.com